102 related articles for article (PubMed ID: 2550648)
41. Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008).
Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2009 Oct; 65(2):158-62. PubMed ID: 19748426
[TBL] [Abstract][Full Text] [Related]
42. Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus.
Bennett JW; Murray CK; Holmes RL; Patterson JE; Jorgensen JH
Diagn Microbiol Infect Dis; 2008 Apr; 60(4):437-40. PubMed ID: 18096352
[TBL] [Abstract][Full Text] [Related]
43. The effects of ultraviolet radiation on antibiotic-resistant bacteria in vitro.
Conner-Kerr TA; Sullivan PK; Gaillard J; Franklin ME; Jones RM
Ostomy Wound Manage; 1998 Oct; 44(10):50-6. PubMed ID: 9866596
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005).
Pfaller MA; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2007 Apr; 57(4):459-65. PubMed ID: 17240105
[TBL] [Abstract][Full Text] [Related]
45. Effect of antibiotic concentration on the killing of Staphylococcus aureus and Enterococcus faecalis: comparison of the novel penem, Men 10700, with other beta-lactam antibiotics.
Hamilton-Miller JM; Shah S
J Antimicrob Chemother; 1999 Sep; 44(3):418-20. PubMed ID: 10511416
[No Abstract] [Full Text] [Related]
46. Daptomycin is effective as antibiotic-lock therapy in a model of Staphylococcus aureus catheter-related infection.
Meije Y; Almirante B; Del Pozo JL; Martín MT; Fernández-Hidalgo N; Shan A; Basas J; Pahissa A; Gavaldà J
J Infect; 2014 Jun; 68(6):548-52. PubMed ID: 24412247
[TBL] [Abstract][Full Text] [Related]
47. In vitro activity of daptomycin against multidrug-resistant Staphylococcus aureus and S. aureus with known virulence factors, including community-acquired methicillin-resistant isolates.
Anastasiou DM; Morgan M; Ruane PJ; Steenbergen JN; Katz BD; Alder JD; Thorne GM
Diagn Microbiol Infect Dis; 2008 Jul; 61(3):339-42. PubMed ID: 18304772
[TBL] [Abstract][Full Text] [Related]
48. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
Drago L; Nicola L; De Vecchi E
Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336
[TBL] [Abstract][Full Text] [Related]
49. In vitro activity of daptomycin versus linezolid and vancomycin against gram-positive uropathogens and ampicillin against enterococci, causing complicated urinary tract infections.
Wagenlehner FM; Lehn N; Witte W; Naber KG
Chemotherapy; 2005 May; 51(2-3):64-9. PubMed ID: 15870498
[TBL] [Abstract][Full Text] [Related]
50. Comprehensive analysis of phospholipids and glycolipids in the opportunistic pathogen Enterococcus faecalis.
Rashid R; Cazenave-Gassiot A; Gao IH; Nair ZJ; Kumar JK; Gao L; Kline KA; Wenk MR
PLoS One; 2017; 12(4):e0175886. PubMed ID: 28423018
[TBL] [Abstract][Full Text] [Related]
51. Daptomycin disrupts membrane potential in growing Staphylococcus aureus.
Alborn WE; Allen NE; Preston DA
Antimicrob Agents Chemother; 1991 Nov; 35(11):2282-7. PubMed ID: 1666494
[TBL] [Abstract][Full Text] [Related]
52. Array synthesis of novel lipodepsipeptide.
Siedlecki J; Hill J; Parr I; Yu X; Morytko M; Zhang Y; Silverman J; Controneo N; Laganas V; Li T; Li J; Keith D; Shimer G; Finn J
Bioorg Med Chem Lett; 2003 Dec; 13(23):4245-9. PubMed ID: 14623010
[TBL] [Abstract][Full Text] [Related]
53. Induction of Daptomycin Tolerance in Enterococcus faecalis by Fatty Acid Combinations.
Brewer W; Harrison J; Saito HE; Fozo EM
Appl Environ Microbiol; 2020 Oct; 86(20):. PubMed ID: 32801181
[No Abstract] [Full Text] [Related]
54. Daptomycin exerts bactericidal activity without lysis of Staphylococcus aureus.
Cotroneo N; Harris R; Perlmutter N; Beveridge T; Silverman JA
Antimicrob Agents Chemother; 2008 Jun; 52(6):2223-5. PubMed ID: 18378708
[TBL] [Abstract][Full Text] [Related]
55. Enterococcus faecalis Responds to Individual Exogenous Fatty Acids Independently of Their Degree of Saturation or Chain Length.
Saito HE; Harp JR; Fozo EM
Appl Environ Microbiol; 2018 Jan; 84(1):. PubMed ID: 29079613
[No Abstract] [Full Text] [Related]
56. Visualization of cell-cell contact during conjugation in Streptococcus faecalis.
Krogstad DJ; Smith RM; Moellering RC; Parquette AR
J Bacteriol; 1980 Feb; 141(2):963-7. PubMed ID: 6767697
[TBL] [Abstract][Full Text] [Related]
57. Single-dose pharmacokinetics and antibacterial activity of daptomycin, a new lipopeptide antibiotic, in healthy volunteers.
Woodworth JR; Nyhart EH; Brier GL; Wolny JD; Black HR
Antimicrob Agents Chemother; 1992 Feb; 36(2):318-25. PubMed ID: 1318678
[TBL] [Abstract][Full Text] [Related]
58. Effect of minor pH changes on the in-vitro activity of azithromycin and clarithromycin.
Fuchs PC; Barry AL; Brown SD
J Antimicrob Chemother; 1997 Jan; 39(1):109-10. PubMed ID: 9044039
[No Abstract] [Full Text] [Related]
59. A turbidimetric and electron microscopic study of the effects of several parameters on the lysis of Streptococcus faecalis by lysozyme.
Carvalho ME; Gonçalves MH; Silva MT
Can J Microbiol; 1984 Jul; 30(7):905-15. PubMed ID: 6434170
[TBL] [Abstract][Full Text] [Related]
60. The effects of daptomycin on cell wall biosynthesis in Enterococcal faecalis.
Rimal B; Chang J; Liu C; Rashid R; Singh M; Kim SJ
Sci Rep; 2023 Jul; 13(1):12227. PubMed ID: 37507537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
